Detail of > 99522-79-9
- CAS Number:
- 99522-79-9
- Name:
3,5-Pyridinedicarboxylicacid, 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-, 3-methyl5-[(2E)-3-phenyl-2-propen-1-yl] ester
- Superlist Name:
- Pranidipine
- Formula:
- C25H24N2O6
- Molecular Structure:
![Molecular Structure of 99522-79-9 (3,5-Pyridinedicarboxylicacid, 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-, 3-methyl5-[(2E)-3-phenyl-2-propen-1-yl] ester)](http://www.lookchem.com/300w/2010/0625/99522-79-9.jpg)
- Synonyms:
- 3,5-Pyridinedicarboxylicacid, 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-, methyl(2E)-3-phenyl-2-propenyl ester (9CI);3,5-Pyridinedicarboxylic acid,1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-, methyl 3-phenyl-2-propenyl ester,(E)-;FRC 8411;OPC 13340;
- Molecular Weight:
- 448.47
- Density:
- 1.254 g/cm3
- Melting Point:
- 140-142 °C
- Boiling Point:
- 618.9 °C at 760 mmHg
- Flash Point:
- 328.1 °C
- Appearance:
- yellow solid
Related products
- 99522-79-93,5-Pyridinedicarboxylicacid, 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-, 3-methyl5-[(2E)-3-phenyl-2-propen-1-yl] ester
- 86781-08-03,5-Pyridinedicarboxylicacid, 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-, 3-(cyclopropylmethyl)5-ethyl ester
- 108914-31-43,5-Pyridinedicarboxylicacid, 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-,3-[(2,2-dimethyl-1,3-dioxolan-4-yl)methyl] 5-methyl ester
- 22609-73-03,5-Pyridinedicarboxylicacid, 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-, 3,5-bis(2-propoxyethyl)ester
- 74936-72-43,5-Pyridinedicarboxylicacid, 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-, 3-methyl ester
- 21829-28-73,5-Pyridinedicarboxylicacid, 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-, 3,5-diethyl ester
- 55985-32-53,5-Pyridinedicarboxylicacid, 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-, 3-methyl5-[2-[methyl(phenylmethyl)amino]ethyl] ester
- 100427-26-73,5-Pyridinedicarboxylicacid, 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-,3-[2-[(3,3-diphenylpropyl)methylamino]-1,1-dimethylethyl] 5-methyl ester
Other Products
- Titanium Dioxide Carbon black Glutathione Adenosine Cable pulling lubricant
- 2973-50-4Benzeneacetonitrile,2-amino-
- 99522-79-93,5-Pyridinedicarboxylicacid, 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-, 3-methyl5-[(2E)-3-phenyl-2-propen-1-yl] ester
- 9007-27-6Chondroitin
- 33403-97-34-Pyridinemethanamine,N-ethyl-
- 32634-95-0Pregn-4-ene-3,20-dione,17-(acetyloxy)-6-methylene-
- 161948-70-51-Piperidinecarboxylicacid, 4-(carboxymethoxy)-, 1-(1,1-dimethylethyl) ester
- 11075-38-0C.I. Acid Brown 50(9CI)
- 12035-35-7Neodymium telluride
- 40138-16-7Boronicacid, B-(2-formylphenyl)-
- 20059-73-8Benzenemethanamine,4-[2-(dimethylamino)ethoxy]-
- 12125-08-5Osmate(2-),hexachloro-, ammonium (1:2), (OC-6-11)-
- 16958-85-3Hexadecanoic acid,octyl ester
- 77658-39-0Kaur-16-en-18-oic acid,9-hydroxy-15-oxo-,(4R)-
- 2506-41-4Naphthalene,2-(chloromethyl)-
- 69202-24-02-Thiophenecarboxylicacid, 5-(4-methoxyphenyl)-, hydrazide
Refine Suppliers Do you want your product ranking ahead? Know what is 'Top Seller'!
- Supplier Location:
China (Mainland)(10)
- Business Type:
- Importer/Exporter(7)
- Certificates:
- ISO (0) Production License (0)
Please post your buying leads,so that our qualified suppliers
will soon contact you!
*Required Fields
Reference
- Polymorphism of methyl (E)-3-phenyl-2-propenyl-1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)pyridi ne-3,5-dicarboxylate (FRC-8411)
- Polymorphism of methyl (E)-3-phenyl-2-propenyl-1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)pyridi ne-3,5-dicarboxylate (FRC-8411). Watanabe, Daiichi; Fukutani, Takashi; Ikawa, Hiroshi; Yamaura, Tetsuaki; Kase, Noriko; Mizutani, Hiroko (Cent. Res. Lab., Fujirebio Inc., Tokyo 192, Japan). Chem. Pharm. Bull., 34(11), 4855-8 (English) 1986. CODEN: CPBTAL. ISSN: 0009-2363. DOCUMENT TYPE: Journal CA Section: 63 (Pharmaceuticals) Section cross-reference(s): 1 Two crystal forms of FRC-8411 (I) [99522-79-9] were obtained by recrystn. from MeOH. These crystal forms were identified by using powder x-ray diffractometry, IR spectroscopy, and thermogravimetry. The m.ps. of forms I and II were 140 and 121°, resp., as shown by DSC. Forms I and II, having a similar particle size distribution, were administered orally or i.v. to spontaneously hypertensive rats. In the case of oral administration, the hypotensive action of form I was milder than that of form II and tachycardia was not obsd. after administration of form I.
- About us
- |
- Payment
- |
- Contact us
- |
- Links
- |
- Help Center
- |
- Disclaimer
- |
- Add to favorite
- | SiteMap
- |
- Product SiteMap
- |
- Manufacturers
- |
- Suppliers
©2008 LookChem.com,License:ICP NO.:Zhejiang10014259
[Hangzhou]86-571-85317600,85317603,85317620

